Radiation modulators for head and neck cancer.

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201300021C
Awardee
Awarding agency
Obligated
$249,672

Award facts

Contract value 100% obligated
$249,672.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 13 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Estes Park, CO 80517, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 4 $0
Change Order 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $249,672

About this award

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Suvica Inc., a for-profit, woman-owned small disadvantaged business. The $249,672.00 firm-fixed-price contract is for the development of "Radiation Modulators for Head and Neck Cancer" with a period of performance ending on August 31, 2014. The contract was set aside for total small business participation.

Quick answers

Who was awarded contract HHSN261201300021C?

HHSN261201300021C was awarded to Suvica Inc. by National Cancer Institute (National Institutes of Health) on September 12, 2013.

How much is contract HHSN261201300021C worth?

The government has obligated $249,672 on HHSN261201300021C.

Was contract HHSN261201300021C competed?

The extent of competition for HHSN261201300021C was full and open competition after exclusion of sources. The government received 13 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award